Redpoint Bio Corporation, a biotechnology company, engages in the discovery, development, and commercialization of taste enhancers and taste blockers for the food, beverage, and pharmaceutical industries in the United States. The company�s food and beverage program focuses on identifying flavor enhancers that improve the taste of existing ingredients; and contribute to the development of healthier, better-tasting foods, and beverages. Its pharmaceutical program uses a biochemical approach aimed at suppressing the bitterness of medicines. The company has a joint research and development, and license agreement with Givaudan Schweiz AG for the development and commercialization of compounds that enhance sweetness or savory sensation, as well as compounds that block or desensitize bitter taste for use in the food and beverage industry; and research agreement with Coca-Cola for the development of certain technology for use in non-alcoholic beverages. It also has an agreement to collaborate with Schering Corporation, in the area of taste science research for pharmaceutical applications. The company is based in Ewing, New Jersey.